Americans aren’t OK with generative healthcare AI that was developed without physicians and is sold by vendors without track records. 

Big as it is, the hospital piece represented just a 2.2% bump over 2021—a modest increase compared with 2021’s spike of 4.5% over 2020.

Prosecutors successfully argued that the patient would not have died if clinicians had ordered a routine CT exam. 

Bipartisan legislation intended to lower healthcare costs by lifting price transparency has made it through the U.S. House of Representatives.

At a time when patient assaults against nurses are reportedly on the rise, cases that invert the equation only reinforce the public’s perception that hospitals are chaotic places.

In its annual outlook report released this week, Fitch Ratings says the coming calendar year will probably strike much of the sector as “another make or break” period.

Artificial intelligence researchers are making a “great plea” to guide the ethical development and use of generative AI in medicine.

How do changes in ownership impact patient care? That was one of the many topics explored in a new survey of U.S. physicians.